The dose, the weight, and the glucose on one line.
A titration is a sequence, not a number. What changed in the four weeks after a step up, whether the nausea tracked the dose or the week, what the weight was doing while the glucose came down — those are questions about a timeline, and they are the questions you get asked in a ten minute appointment. SteadyRange keeps that timeline.
Start with what you are already taking
Your medication list is the first thing SteadyRange builds a timeline around. Name it here and it is waiting for you, filled in, the moment you have an account.
You will land on your medication list with Ozempic already entered — editable, in case you are mid-step.
Logging is free and stays free. SteadyRange records the dose you were prescribed; it never suggests one.
Sixteen weeks, one chart
Below is a sample record: a daily glucose average, a weight trend, and four numbered dose markers, drawn by the same component that draws a real member’s. Read down a marker to see the weeks that followed it.
- 1May 22Started · 0.25 mg weekly
- 2Jun 19Increased · 0.5 mg weekly
- 3Jul 17Increased · 1 mg weekly
- 4Aug 14Increased · 1.7 mg weekly
Why the middle matters
Week four and week twelve of that same sample, side by side. Neither week is remarkable on its own; the difference between them is the whole conversation, and it is invisible to anyone holding a fortnight of readings.
- Average glucose
- 145 mg/dL
- Days averaging in range
- 7 of 7
- BMI
- 33.0
- Average glucose
- 134 mg/dL
- Days averaging in range
- 7 of 7
- BMI
- 31.9
Across those eight weeks the sample’s average came down 11 mg/dL and its BMI came down 1.1. Whether that is the medication, the season, or the fact that someone started paying attention is not a question a chart can settle — it is a question a chart lets you and your clinician have.
What lands on the timeline
The dose, as it was written
Every injection, every step up, and every week you held steady — recorded on the date it happened. Not a plan, a record: what you were actually prescribed and actually took.
Weight and glucose against it
Both series sit on the same axis as the dose markers, so the question a clinician asks — did the last change do anything? — is answered by looking down rather than by remembering.
The side effects, on the same dates
Nausea in week three and nausea in week nine are different facts about a titration. Notes land on the timeline beside the dose that was in force when you wrote them.
One page your prescriber can open
A private link or a PDF that shows the ladder and the numbers together — no account, no app, no login on their end.
The one-off questions
Two free tools, no account, nothing stored:
- GLP-1 weight loss calculator — projects the published trial curves onto your start weight.
- GLP-1 half-life — how levels build after a step up, and how long they take to clear.
- GLP-1 dosing and titration explained — why doses step up slowly, in plain language.
What this is not
SteadyRange is a logbook, not a prescriber and not a medical device. It does not recommend a drug, suggest a dose, tell you when to step up, or tell you when to stop. It has no opinion about whether you should be on a GLP-1 at all. It records what you were prescribed and shows you what happened next, which is a smaller job than the one a clinician does and a different one.
Your readings are yours: never sold, never used for advertising, exportable in full at any time, and deletable in full at any time. The security page says where they physically sit and which companies touch them.
See your own curve, not just clinical trial averages
Trial curves show the population average. SteadyRange records your actual weekly doses, weigh-ins, and fasting blood sugar together so you and your prescriber see how your body steadies over time, on a private log you control.